High-sensitivity C-reactive protein is an independent marker of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease


    loading  Checking for direct PDF access through Ovid

Abstract

BackgroundCoronary endothelial dysfunction (CED) is an early stage of atherosclerosis and is associated with adverse cardiovascular events. Inflammation may play a role in the development of endothelial dysfunction. To date no study has evaluated the relationship between C-reactive protein and CED. We aimed to determine if C-reactive protein is associated with CED.MethodsIn 1016 patients (mean age 50.7 ± 12.3 years, 34% male) presenting to the catheterization laboratory with chest pain and non-obstructive coronary artery disease, coronary vasoreactivity was assessed by measuring the percent change in coronary blood flow (%ΔCBF) and coronary artery diameter (%ΔCAD) in response to intracoronary acetylcholine. Plasma high sensitivity C-reactive protein (hs-CRP) was measured and patients were divided into 2 groups: hs-CRP ≤ 3.0 mg/L (low-intermediate cardiovascular risk n = 169) and 3 mg/L < hs-CRP ≤ 10 mg/L (high cardiovascular risk n = 847).ResultsPatients with a high risk hs-CRP had a significantly lower %ΔCBF and %ΔCAD in response to acetylcholine vs low risk hs-CRP (43.8 ± 6.1 vs 65.8 ± 4.5, P = .004 and −17.2 ± 1.5 vs −13.1 ± 0.8, P = .02 respectively). Low risk hs-CRP was associated with significantly higher %ΔCBF and %ΔCAD vs high risk hs-CRP (27.1 ± 11.0, P = .01 and 4.5 ± 1.9, P = .02 respectively). CED was associated with significantly higher hs-CRP levels and high risk hs-CRP was independently associated with abnormal coronary vasoreactivity, OR 1.82 (95% CI 1.25–2.69).ConclusionsHs-CRP is independently associated with and a strong predictor of abnormal coronary vasoreactivity in patients with non-obstructive coronary artery disease.

    loading  Loading Related Articles